NDC 62756-589 – Liothyronine sodium

Liothyronine Sodium 5 ug/1 · Tablet · Oral

Human Prescription Drug 3 recalls

Product NDC62756-589

Product details

Brand name
Liothyronine sodium
Generic name
Liothyronine sodium
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA091382
Marketed since
November 28, 2019
Listing expires
December 31, 2026
Pharmacologic class
l-Triiodothyronine

Active ingredients

Uses, dosage, side effects and warnings for Liothyronine Sodium →

Package NDC codes (5)

Package NDCDescriptionSince
62756-589-0190 TABLET in 1 BOTTLE (62756-589-01)Jun 26, 2023
62756-589-08100 TABLET in 1 BOTTLE (62756-589-08)Nov 28, 2019
62756-589-181000 TABLET in 1 BOTTLE (62756-589-18)Nov 28, 2019
62756-589-8330 TABLET in 1 BOTTLE (62756-589-83)Nov 28, 2019
62756-589-88100 TABLET in 1 BOTTLE (62756-589-88)Nov 28, 2019

Recalls mentioning this NDC

Other Liothyronine Sodium products